Preview this article:
Zoom in

Bulgarian cystic fibrosis isolates: antimicrobial susceptibility and neuraminidase-encoding gene distribution, Page 1 of 1

| /docserver/preview/fulltext/jmm/58/5/690-1.gif

There is no abstract available for this article.
Use the preview function to the left.


Article metrics loading...

Loading full text...

Full text loading...



  1. Burns, J. L., Saiman, L., Whittier, S., Larone, D., Krzewinski, J., Liu, Z., Marshall, S. A. & Jones, R. N. ( 2000; ). Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol 38, 1818–1822.
    [Google Scholar]
  2. Ciofu, O., Fussing, V., Bagge, N., Koch, C. & Høiby, N. ( 2001; ). Characterization of pared mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, β-lactamase activity and ribotyping. J Antimicrob Chemother 48, 391–396.[CrossRef]
    [Google Scholar]
  3. CLSI ( 2005; ). Performance Standards for Antimicrobial Susceptibility Testing, 15th informational supplement, M100–S15. Wayne, PA: Clinical and Laboratory Standards Institute.
  4. CFF ( 2002; ). Patient Registry 2001 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation.
  5. Davies, J., Dewar, A., Bush, A., Pitt, T., Gruenert, D., Geddes, D. M. & Alton, E. W. ( 1999; ). Reduction in the adherence of Pseudomonas aeruginosa to native cystic fibrosis epithelium with anti-asialoGM1 antibody and neuraminidase inhibition. Eur Respir J 13, 565–570.[CrossRef]
    [Google Scholar]
  6. Govan, J. R. & Deretic, V. ( 1996; ). Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60, 539–574.
    [Google Scholar]
  7. Johansen, H. K., Moskowitz, S. M., Ciofu, O., Pressler, T. & Høiby, N. ( 2008; ). Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros 7, 391–397.[CrossRef]
    [Google Scholar]
  8. Lanotte, P., Watt, S., Mereghetti, L., Dartiguelongue, N., Rastegar-Lari, A., Goudeau, A. & Quentin, R. ( 2004; ). Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J Med Microbiol 53, 73–81.[CrossRef]
    [Google Scholar]
  9. Morosini, M. I., Garcia-Castillo, M., Loza, E., Perez-Vazquez, M., Baquero, F. & Canton, R. ( 2005; ). Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients: use of high-range E-test strips. J Clin Microbiol 43, 4480–4485.[CrossRef]
    [Google Scholar]
  10. Pitt, T. L., Sparrow, M. & Stefanidou, M. ( 2003; ). Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax 58, 794–796.[CrossRef]
    [Google Scholar]
  11. Ramsey, B. W. ( 1996; ). Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 335, 179–188.[CrossRef]
    [Google Scholar]
  12. Srifuengfung, S., Tiensasitorn, C., Yungyuen, T. & Dhirapurta, C. ( 2004; ). Prevalence and antimicrobial susceptibility of Pseudomonas aeruginosa mucoid and non-mucoid type. Southeast Asian J Trop Med Public Health 35, 893–896.
    [Google Scholar]
  13. Strateva, T. ( 2008; ). Microbiological and molecular-genetic investigations on the resistance mechanisms and virulence factors in clinical strains of Pseudomonas aeruginosa. PhD thesis, Medical University of Sofia.

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error